-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On Apotex Health with Buy Rating, Announces Price Target of C$42

Benzinga·07/13/2026 18:30:44
語音播報
Canaccord Genuity analyst Tania Armstrong-Whitworth initiates coverage on Apotex Health (TSX:APTX) with a Buy rating and announces Price Target of C$42.